Garry Arthur Neil, Chief Scientific Officer at Aevi Genomic Medicine, Inc. (GNMX), bought 75,000 shares at $1.26 ($95K) on 2017-10-17, disclosed to the SEC on 2017-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVTX | BUY | 2021-12-14 | $7K | — | Filing → |
| CERC | BUY | 2021-06-14 | $8K | — | Filing → |
| CERC | BUY | 2020-12-14 | $8K | — | Filing → |